Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3778-3785

  Jonson, Gunhild ^a   Osek, Jacek ^a,b   Svennerholm, Ann Mari ^a   Holmgren, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN RECOGNITION; ARTICLE; CHOLERA; IMMUNE RESPONSE; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIBRIO CHOLERAE;

EID: 0029757453     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3778-3785.1996     Document Type: Article

References (43)

1. Al Hendy, A., P. Toivanen, and M. Skurnik. 1991. Rapid method for isolation and staining of bacterial lipopolysaccharide. Microbiol. Immunol. 35:331-333.
2. Attridge, S. R., E. Voss, and P. A. Manning. 1993. The role of toxin-coregulated pili in the pathogenesis of Vibrio cholerae O1 El Tor. Microb. Pathog. 15:421-431.
3. Bhattacharya, M. K., S. K. Bhattacharya, S. Garg, P. K. Saha, D. Dutta, G. B. Nair, B. C. Deb, and K. P. Das. 1993. Outbreak of Vibrio cholerae non-O1 in India and Bangladesh. Lancet 341:1346-1347.
4. Bik, E. M., A. E. Bunschoten, R. D. Gouw, and F. R. Mooi. 1995. Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J. 14:209-216.
5. Calia, K. E., M. Murtagh, M. J. Ferraro, and S. B. Calderwood. 1994. Comparison of Vibrio cholerae O139 with V. cholerae O1 classical and El Tor biotypes. Infect. Immun. 62:1504-1506.
6. Comstock, L. E., J. A. Johnson, J. M. Michalski, J. G. Morris, and J. B. Kaper. 1996. Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol. Microbiol. 19:815-826.
7. De St. Groth, S. F., and D. J. Scheidegger. 1980. Production of monoclonal antibodies. Strategy and tactics. J. Immunol. Methods 35:1-21.
8. Dubey, R. S., M. Lindblad, and J. Holmgren. 1990. Purification of El Tor cholera enterotoxins and comparison with classical toxin. J. Gen. Microbiol. 136:1839-1847.
9. Finkelstein, R. A., P. Atthasampunna, M. Chulasamaya, and P. Charunmethee. 1966. Pathogenesis of experimental cholera. Biological activities of purified procholeragen. J. Immunol. 96:440-449.
10. Finkelstein, R. A., M. Boesman-Finkelstein, Y. Chang, and C. C. Häse. 1992. Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect. Immun. 60:472-478.
11. Glass, R. I., S. Becker, M. I. Huq, B. J. Stoll, M. U. Khan, M. H. Merson, J. V. Lee, and R. E. Black. 1982. Endemic cholera in rural Bangladesh, 1996-1980. Am. J. Epidemiol. 116:959-970.
12. Guerrant, R. L., L. L. Brunton, T. C. Schnaitman, L. I. Rebhun, and A. G. Gilman. 1974. Cyclic adenosinc monophosphate and alteration of Chinese hamster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect. Immun. 10:320-327.
13. Hall, R. H., F. M. Khambaty, M. H. Kothary, S. P. Keasler, and B. D. Tall. 1994. Vibrio cholerae non-O1 serogroup associated with cholera gravis genetically and physiologically resembles O1 El Tor cholera strains. Infect. Immun. 62:3859-3863.
14. Higa, N., Y. Honma, M. J. Albert, and M. Iwanaga. 1993. Characterization of Vibrio cholerae O139 synonym Bengal isolated from patients with cholera-like disease in Bangladesh. Microbiol. Immunol. 37:971-974.
15. Hisatsune, K., S. Kondo, Y. Isshiki, T. Iguchi, Y. Kawamata, and T. Shimada. 1993. O-antigenic lipopolysaccharide of Vibrio cholerae O139 Bengal, a new epidemic strain for recent cholera in the Indian subcontinent. Biochem. Biophys. Res. Commun. 196:1309-1315.
16. Holmgren, J., J. Osek, and A.-M. Svennerholm. 1994. Protective oral cholera vaccine based on a combination of cholera toxin B subunit and inactivated cholera vibrios, p. 415-424. In K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. American Society for Microbiology, Washington, D.C.
17. Jertborn, M., A.-M. Svennerholm, and J. Holmgren. 1986. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J. Clin. Microbiol. 24:203-209.
18. 17a Jertborn, M., A.-M. Svennerholm, and J. Holmgren. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine. Vaccine, in press.
19. Johnson, J. A., C. A. Salles, P. Panigrahi, M. J. Albert, A. C. Wright, R. J. Johnson, and J. G. Morris, Jr. 1994. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect. Immun. 62:2108-2110.
20. Jonson, G., J. Holmgren, and A.-M. Svennerholm. 1991. Epitope differences in toxin coregulated pili produced by classical and El Tor Vibrio cholerae O1. Microb. Pathog. 11:179-188.
21. Jonson, G., J. Holmgren, and A.-M. Svennerholm. 1991. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microb. Pathog. 11:433-441.
22. Jonson, G., J. Holmgren, and A.-M. Svennerholm. 1992. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo. Infect. Immun. 60:4278-4284.
23. Jonson, G., M. Lebens, and J. Holmgren. 1994. Cloning and comparison of the mannose-sensitive hemagglutinin pilin gene in Vibrio cholerae serogroup O1 and O139, abstr. BS-21/37. In Abstract book of 7th International Congress of Bacteriology and Applied Microbiology Division. Czechoslovak Society for Microbiology, Prague.
24. 22a.Jonson, G., A.-M. Svennerholm, and J. Holmgren. 1989. Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture. Infect. Immun. 57:1809-1815.
25. Kido, N., M. Onto, and N. Kato. 1990. Detection of lipopolysaccharide by ethidium bromide staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Bacteriol. 172:1145-1147.
26. Lebens, M., and J. Holmgren. 1994. Structure and arrangement of the cholera toxin genes in Vibrio cholerae O139. FEMS Microbiol. Lett. 117:197-202.
27. Lindholm, L., J. Holmgren, M. Wikström, U. Karlsson, K. Andersson, and N. Lycke. 1983. Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin. Infect. Immun. 40:570-576.
28. Osek, J., A.-M. Svennerholm, and J. Holmgren. 1992. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili. Infect. Immun. 60:4961-4964.
29. Rhine, J. A., and R. K. Taylor. 1994. TcpA pilin sequences and colonization requirements for O1 and O139 Vibrio cholerae. Mol. Microbiol. 13:1013-1020.
30. Rice, E. W. C., J. Johnson, R. M. Clark, K. R. Fox, D. J. Reasoner, M. E. Dunnigan, P. Panigrabi, J. A. Johnson, and J. G. Morris, Jr. 1992. Chlorine and survival of "rugose" Vibrio cholerae. Lancet 340:740.
31. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
32. Siddique, A. K., K. Zaman, A. H. Baqui, K. Akram, P. Mutsuddy, A. Eusof, K. Haider, S. Islam, and R. B. Sack. 1992. Cholera epidemics in Bangladesh: 1985-1991. J. Diarrhoeal Dis. Res. 10:79-86.
33. Stroeher, U. H., K. E. Jedani, B. K. Dredge, R. Morona, M. H. Brown, L. E. Karageorgos, M. J. Albert, and P. A. Manning. 1995. Genetic rearrangements in the rfb regions of Vibrio cholerae O1 and O139. Proc. Natl. Acad. Sci. USA 92:10374-10378.
34. Svennerholm, A.-M., and J. Holmgren. 1976. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect. Immun. 13:735-740.
35. Svennerholm, A.-M., and J. Holmgren. 1978. Identification of Escherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure. Curr. Microbiol. 1:19-23.
36. Svennerholm, A.-M., G. Jonson Strömberg, and J. Holmgren. 1983. Purification of Vibrio cholerae soluble hemagglutinin and development of enzyme-linked immunosorbent assays for antigen and antibody quantitations. Infect. Immun. 41:237-243.
37. Voss, E., and S. R. Attridge. 1993. In vitro production of toxin-coregulated pili by Vibrio cholerae El Tor. Microb. Pathog. 15:255-268.
38. 35a.Voss, E., and S. R. Attridge. Personal communication.
39. Voss, E., P. A. Manning, and S. A. Attridge. Submitted for publication.
40. Waldor, M. K., R. Colwell, and J. J. Mekalanos. 1994. The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants. Proc. Natl. Acad. Sci. USA 91:11388-11392.
41. Waldor, M. K., and J. J. Mekalanos. 1994. ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera. Infect. Immun. 62:72-78.
42. Waldor, M. K., and J. J. Mekalanos. 1994. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J. Infect. Dis. 70:278-283.
43. Weintraub, A. G., P.-E. Widmalm, M. Jansson, K. Hultenby, and M. J. Albert. 1994. Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence. Microb. Pathog. 16:235-241.